Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a ...

LLY rides high on surging demand for Mounjaro and Zepbound, now nearly half its revenues ahead of Q2 earnings.

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

BENGALURU] European shares closed lower on Friday (Jul 11), as losses in banks and healthcare stocks weighed at the end of a ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

European shares closed lower on Friday, as losses in banks and healthcare stocks weighed at the end of a week marred by US ...

Wockhardt announces its exit from the US generics market, shifting focus to its innovative antibiotic and biologicals ...

Nandita Vijayasimha, Bengaluru Saturday, July 12, 2025, 08:00 Hrs [IST] ...

TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.